000513.SZ · 丽珠集团
China A-shares · RS rating 44 · As of 2026-10-14
| Price | 28.01 CNY |
|---|---|
| 1-day change | -4.8% |
| RS rating (overall / 1M / 3M / 12M) | 44 / 85 / 39 / 28 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 17 / 12 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -25.9% |
| Distance from 52-week high | +28.1% |
| Market cap (USD) | $4.1B |